Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
Judith M. Versluis, Irene L. M. Reijers, Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi, Michel W.J.M. Wouters, Sydney Ch’ng, Robyn P.M. Saw, Richard A. Scolyer, Bart A. van de Wiel, Bastian Schilling, Georgina V. Long, Christian U. Blank
Topics & Concepts
MedicineIpilimumabNivolumabMelanomaNeoadjuvant therapyOncologyLymphadenectomyLymph nodeInternal medicineStage (stratigraphy)Primary tumorImmunotherapyMetastasisCancerCancer researchBiologyPaleontologyBreast cancerCutaneous Melanoma Detection and ManagementMelanoma and MAPK PathwaysCancer Immunotherapy and Biomarkers